- Home
- HTGC vs SRRK Comparison
HTGC vs SRRK Comparison
Compare HTGC & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HTGC
- SRRK
- Stock Information
- Founded
- HTGC 2003
- SRRK 2012
- Country
- HTGC United States
- SRRK United States
- Employees
- HTGC N/A
- SRRK N/A
- Industry
- HTGC Investment Managers
- SRRK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HTGC Finance
- SRRK Health Care
- Exchange
- HTGC Nasdaq
- SRRK Nasdaq
- Market Cap
- HTGC 3.2B
- SRRK 2.8B
- IPO Year
- HTGC 2005
- SRRK 2018
- Fundamental
- Price
- HTGC $17.57
- SRRK $29.76
- Analyst Decision
- HTGC Buy
- SRRK Strong Buy
- Analyst Count
- HTGC 8
- SRRK 6
- Target Price
- HTGC $20.81
- SRRK $42.17
- AVG Volume (30 Days)
- HTGC 1.5M
- SRRK 1.0M
- Earning Date
- HTGC 05-01-2025
- SRRK 05-14-2025
- Dividend Yield
- HTGC 10.70%
- SRRK N/A
- EPS Growth
- HTGC N/A
- SRRK N/A
- EPS
- HTGC 1.33
- SRRK N/A
- Revenue
- HTGC $491,549,000.00
- SRRK N/A
- Revenue This Year
- HTGC $7.53
- SRRK N/A
- Revenue Next Year
- HTGC $9.61
- SRRK $452.64
- P/E Ratio
- HTGC $13.20
- SRRK N/A
- Revenue Growth
- HTGC 3.02
- SRRK N/A
- 52 Week Low
- HTGC $15.65
- SRRK $6.76
- 52 Week High
- HTGC $22.04
- SRRK $46.98
- Technical
- Relative Strength Index (RSI)
- HTGC 47.85
- SRRK 46.26
- Support Level
- HTGC $17.35
- SRRK $28.29
- Resistance Level
- HTGC $17.74
- SRRK $31.60
- Average True Range (ATR)
- HTGC 0.28
- SRRK 1.57
- MACD
- HTGC 0.02
- SRRK -0.13
- Stochastic Oscillator
- HTGC 54.76
- SRRK 28.79
About HTGC Hercules Capital Inc.
Hercules Capital Inc is a specialty finance company that provides senior secured loans to high-growth, venture capital-backed companies in various technology, life sciences, and sustainable and renewable technology industries. It invests majorly in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The company lends to and invests in portfolio companies in various technology-related industries, including technology, drug discovery and development, biotechnology, life sciences, healthcare, and sustainable and renewable technology.
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.